Gabriel Chan, Ali Taqi, Paul Marotta, Mark Levstik, Vivian McAlister, William Wall, Douglas Quan – 24 November 2009 – Acute liver failure continues to be associated with a high mortality rate, and emergency liver transplantation is often the only life‐saving treatment. The short‐term outcomes are decidedly worse in comparison with those for nonurgent cases, whereas the long‐term results have not been reported as extensively. We report our center's experience with urgent liver transplantation, long‐term survival, and major complications.

Fumihiro Shoji, Tokujiro Yano, Yuji Soejima, Akinobu Taketomi, Masafumi Takeshita, Katsuo Sueishi, Yoshihiko Maehara – 24 November 2009

Mangesh Pagadala, Srinivasan Dasarathy, Bijan Eghtesad, Arthur J. McCullough – 24 November 2009 – With increasing survival after orthotopic liver transplantation (OLT), metabolic syndrome and its individual components, including diabetes mellitus, hypertension, dyslipidemia, and obesity, are increasingly being identified and contributing to cardiovascular complications and late morbidity and mortality. The prevalence of posttransplant metabolic syndrome (PTMS) and its individual components has been found to be higher post‐OLT versus a comparable population without OLT.

Sheng Yan, Zhenhua Tu, Weifeng Lu, Qiyi Zhang, Jiangjuan He, Zhiwei Li, Yi Shao, Weilin Wang, Min Zhang, Shusen Zheng – 24 November 2009 – Pupil examination has been used as a basic measure in critically ill patients and has great importance for the prognosis and management of disease. An automated pupillometer is a computer‐based infrared digital video system by which the accuracy and precision of the pupil examination are markedly improved.

Javier F. Castroagudín, Esther Molina, Rafael Romero, Esteban Otero, Santiago Tomé, Evaristo Varo – 24 November 2009 – Chronic renal dysfunction is a frequent and severe complication in solid‐organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and sirolimus), can improve renal function in these patients, but available data about the efficacy and safety of everolimus in liver transplant recipients are scarce.

Jacqueline G. O'Leary, Chet R. Rees, Göran B. Klintmalm, Gary L. Davis – 24 November 2009

Tadafumi Asaoka, Tomoaki Kato, Shigeru Marubashi, Keizo Dono, Naoki Hama, Hidenori Takahashi, Shogo Kobayashi, Yutaka Takeda, Ichiro Takemasa, Hiroaki Nagano, Hideo Yoshida, Phillip Ruiz, Andreas G. Tzakis, Kenichi Matsubara, Morito Monden, Yuichiro Doki, Masaki Mori – 24 November 2009 – Histopathological evaluation of the liver via biopsy remains the standard procedure for the diagnosis of both acute cellular rejection (ACR) and recurrent hepatitis C (RHC) after liver transplantation.

24 November 2009

24 November 2009

Zoe A. Stewart, Jayme E. Locke, Dorry L. Segev, Nabil N. Dagher, Andrew L. Singer, Robert A. Montgomery, Andrew M. Cameron – 24 November 2009 – Hepatic artery thrombosis (HAT) is the most common vascular complication after liver transplantation; it has been reported to occur in 2% to 5% of liver transplant recipients. Most reports of HAT in the literature describe single‐center series with small numbers of patients and lack the power to definitively identify nontechnical risk factors.